Table 1.
ZSF1‐lean (n = 11) | ZSF1‐obese (n = 11) | P‐value | |
---|---|---|---|
Blood pressure measurements | |||
Heart rate (bpm) | 328 ± 8 | 353 ± 11 | NS |
Systolic (mm Hg) | 147 ± 2 | 170 ± 6 | 0.005 |
Diastolic (mm Hg) | 108 ± 2 | 130 ± 7 | 0.009 |
Mean (mm Hg) | 120 ± 2 | 143 ± 7 | 0.007 |
Oxygen consumption under maximum effort | |||
VO2max (ml/min/kg0.75) | 28.1 ± 1.5 | 17.5 ± 0.4 | <0.001 |
VCO2 (ml/min/kg0.75) | 25.7 ± 1.3 | 17.8 ± 0.3 | <0.001 |
Peak work rate (m/min/kg) | 19.8 ± 0.9 | 12.9 ± 0.4 | <0.001 |
Total work load (m/Kg) | 150.3 ± 14.9 | 58.5 ± 2.6 | <0.001 |
Echocardiographic parameters | |||
BW (g) | 492 ± 11 | 644 ± 10 | <0.001 |
LVmassInd (g/cm2) | 1.32 ± 0.14 | 2.02 ± 0.15 | 0.006 |
IVRT (ms) | 23.8 ± 1.1 | 29.4 ± 0.9 | <0.001 |
E/A | 1.54 ± 0.06 | 1.27 ± 0.10 | 0.02 |
E/E′ | 13.29 ± 0.92 | 16.96 ± 0.99 | 0.01 |
LAAind | 0.287 ± 0.013 | 0.396 ± 0.011 | <0.001 |
S′ (m/s) | 0.058 ± 0.001 | 0.048 ± 0.002 | 0.002 |
EF (%) | 71 ± 4 | 69 ± 3 | 0.29 |
Pulmonary oedema (g) | 0.384 ± 0.009 | 0.461 ± 0.013 | 0.008 |
BNP (mRNA levels, A.U) | 100.0 ± 0.1 | 190.3 ± 0.2 | <0.001 |
Abbreviations: VO2max and VCO2max, maximal O2 consumption and CO2 production respectively
BW, body weight; LVmassInd, left ventricle mass indexed to body surface area (BSA); EDVI, end‐diastolic volume indexed to BSA; IVRT, isovolumetric relaxation time; E/A, ratio between the peak of pulse Doppler wave of early mitral flow velocity (E) to peak of pulse Doppler wave of late mitral flow velocity (A); E/E′, ratio between E wave and the peak of tissue Doppler velocity at the lateral mitral annulus (E′); LAAind, left atrium area indexed to BSA; S′, peak systolic velocity; EF, ejection fraction; BNP, brain natriuretic peptide. Values are mean ± SEM or threshold cycles for BNP.